University of Arkansas for Medical Sciences, Cancer Institute, Clinical Trials Office Trials

University of Arkansas for Medical Sciences, Cancer Institute, Clinical Trials Office	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Smith, Robert C

H-200-001, NCT04180215 / 2019-000907-34: A Phase 1/2 Study in Patients with HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

Active, not recruiting

1/2

200

Europe, US

HB-201 intravenous administration., HB-202 intravenous administration alternating with HB-201 intravenous administration., HB-201 intravenous administration + standard of care regimen including pembrolizumab., HB-202 / HB-201 alternating intravenous administration + pembrolizumab., HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab., HB-201 or HB-201/HB-202 alternating treatment using CD8 PET Tracer (Zr-Df-IAB22M2C)

Hookipa Biotech GmbH, Hookipa Biotech

HPV-Related Squamous Cell Carcinoma

06/25

06/26

ReChord, NCT02803957: Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair

Recruiting

N/A

585

NeoChord DS1000, Surgical Mitral Valve Repair

NeoChord

Mitral Valve Insufficiency

07/22

07/27

SITRAL, NCT02830204: Surgical Implantation of TRAnscatheter vaLve in Native Mitral Annular Calcification () Study

Completed

N/A

Mitral Valve Replacement with Sapien3, MVR

Baylor Research Institute, Edwards Lifesciences

Mitral Annular Calcification

01/23

09/23

CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting

N/A

1247

Europe, Canada, US

Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System

Edwards Lifesciences

Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation

01/25

04/30

NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN

Recruiting

N/A

1400

Europe, US, RoW

Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation

Medtronic Vascular

Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus

11/26

11/29

INTERMENTAL, NCT05118828: Guided Internet-based Interventions in Primary Care Effectiveness-implementation Randomized Controlled Trial

Active, not recruiting

N/A

1000

Europe

Guided internet-based cognitive behavioural therapy, Treatment as usual in Prompt Mental Health Care (TAU-PMHC)

Norwegian Institute of Public Health, Norwegian Directorate of Health, University of Bergen, Göteborg University, University of Tromso, Sussex Partnership NHS Foundation Trust

Anxiety, Mild to Moderate Depression

08/24

06/26

Reshape-HF2, NCT02444338: A Clinical Evaluation of the Safety and Effectiveness of the MitraClip System in the Treatment of Clinically Significant Functional Mitral Regurgitation

Completed

N/A

505

Europe, RoW

MitraClip, standard of care

University Medical Center Goettingen, University Medical Center Goettingen

Mitral Valve Insufficiency

04/24

NCT04482062: TRISCEND II Pivotal Trial

Active, not recruiting

N/A

1070

Europe, US

Edwards EVOQUE System, Transcatheter tricuspid valve replacement, Optimal Medical Therapy

Edwards Lifesciences

Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure

06/24

12/29

NCT06611579: Clinical Study of the InQB8 TTVR System

Not yet recruiting

N/A

Transcatheter Tricuspid Valve Replacement, inQB8 MonarQ Transcatheter Tricuspid Valve Replacement System

inQB8 Medical Technologies, LLC

Tricuspid Valve Regurgitation

10/26

10/29

ENRAPTUS, NCT04396379: Epicardial Mitral Touch System for Mitral Insufficiency

Not yet recruiting

N/A

Implant an epicardial device to reshape the mitral valve annulus

Mitre Medical Corp., BSWRI Cardiac Imaging Core Lab (CICL)

Ischemic Mitral Regurgitation, Functional Mitral Regurgitation

12/24

12/27

NCT03382457: Clinical Study of Edwards Cardioband FIT Valve Repair System

Recruiting

N/A

Transcatheter Tricuspid Valve Repair, Edwards Cardioband Tricuspid Valve Repair

Edwards Lifesciences

Tricuspid Regurgitation

12/26

12/31

Measure, NCT04430972: Immune Responsiveness and Outcome After Aortic Valve Surgery

Not yet recruiting

N/A

150

Europe

Aortic valve replacement

Barts & The London NHS Trust, University College, London

Aortic Valve Disease, Surgery--Complications, Immune System Disorder

09/25

09/26

APOLLO, NCT03242642: Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.

Recruiting

N/A

1056

Europe, Canada, US

Medtronic Intrepid Transcatheter Mitral Valve Replacement System (TMVR)

Medtronic Cardiovascular

Mitral Valve Regurgitation

10/26

09/36

Romero, Racine

H-200-001, NCT04180215 / 2019-000907-34: A Phase 1/2 Study in Patients with HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

Active, not recruiting

1/2

200

Europe, US

Hookipa Biotech GmbH, Hookipa Biotech

HPV-Related Squamous Cell Carcinoma

06/25

06/26

Luzania, Brandi

H-200-001, NCT04180215 / 2019-000907-34: A Phase 1/2 Study in Patients with HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other Cancers

Active, not recruiting

1/2

200

Europe, US

Hookipa Biotech GmbH, Hookipa Biotech

HPV-Related Squamous Cell Carcinoma

06/25

06/26

BDTX-1535-101, NCT05256290: Phase 1/2 Study of BDTX-1535 in Patients with Glioblastoma or Non-Small Cell Lung Cancer with EGFR Mutations

Recruiting

1/2

200

BDTX-1535 monotherapy

Black Diamond Therapeutics, Inc.

Non-Small Cell Lung Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Lung Cancer, NSCLC, Advanced Lung Carcinoma, Epidermal Growth Factor Receptor C797S, Epidermal Growth Factor Receptor G719X, EGF-R Positive Non-Small Cell Lung Cancer, EGFR-TKI Resistant Mutation

07/25

06/26

BDTX-4933-101, NCT05786924: A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers

Active, not recruiting

100

BDTX-4933

Black Diamond Therapeutics, Inc.

Non-small Cell Lung Cancer, Histiocytic Neoplasm, Histiocytosis, Melanoma, Melanoma (Skin), BRAF Gene Mutation, BRAF V600E, BRAF V600 Mutation, BRAF Mutation-Related Tumors, BRAF, Metastatic Lung Non-Small Cell Carcinoma, Metastatic Melanoma, Metastatic Lung Cancer, Recurrent Melanoma, Recurrent Lung Cancer, Recurrent Lung Non-Small Cell Carcinoma, NSCLC, Solid Tumor, Solid Carcinoma, KRAS G12D, KRAS G12V, KRAS Mutation-Related Tumors, NRAS Gene Mutation, Thyroid Cancer, Thyroid Carcinoma, Colorectal Cancer, Colorectal Carcinoma, Recurrent Histiocytic and Dendritic Cell Neoplasm, Brain Metastases, Recurrent NSCLC, KRAS G13C, Acquired Resistance to KRAS G12C Inhibitor, KRAS G12A, KRAS G12F, KRAS G12R, KRAS G13D

06/26

12/26



	Diseases Companies Products Productz Mechanisms of Action Sites